Loading market data...
Latest Top News
Should You Buy the Dip? Blue Jet’s 10% Crash Has Analysts Divided
1. Earnings Shock Triggers Sharp Sell-Off
Shares of midcap pharma firm Blue Jet Healthcare plunged 10% on July 22, hitting a low of Rs 906.15 on the NSE.
- Q1FY26 net profit dropped 17% quarter-on-quarter to Rs 91 crore
- EBITDA fell 13.1% to Rs 121 crore, with margin...
Stay Ahead – Explore Now! Prism Secures ₹885 Crore Tax Relief Ahead of Planned IPO






